Zengchun Li

695 citations
36 papers · 578 indexed · h-index 14

Zengchun Li

34 papers receiving 570 citations

Peers

Zengchun Li
Comparison fields: 5 of 97
  • Cancer Research 105
  • Renewable Energy, Sustainability and the Environment 94
  • Rheumatology 83
  • Clinical Biochemistry 36
  • Endocrine and Autonomic Systems 31
Replace Xinhui Zhu with:
Xinhui Zhu China
Fengming Luo China
Ahmed M. Elmansi United States
Shuyu Xu China
Linhao You China
Guilin Wang China
Xiaojun Qian China
Yifan Zhang China
Tomoyuki Hisa Japan
Dongha Kim South Korea
Zengchun Li relative to Xinhui Zhu China Xinhui Zhu's profile →
Citations per field
00.5×12×
Xinhui Zhu · 1×
Citations per year

Countries citing papers authored by Zengchun Li

Since Specialization
Citations

This map shows the geographic impact of Zengchun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengchun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengchun Li more than expected).

Fields of papers citing papers by Zengchun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zengchun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengchun Li. The network helps show where Zengchun Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zengchun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zengchun Li Line = papers co-authored together Zengchun Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 20210
3 201735
4 201641
5 20167
6 20165
7 201513
8 20154
9 20154
10
Decreased expression of microRNA-130a correlates with TNF-α in the development of osteoarthritis.
201547
11 20148
12 201418
13 20134
14 201340
15 201213
16 201251
17 201121
18
Study on the characteristics of Chinese developmental reading dyslexia among children.
20101
19
Experiment of Microscale Extraction Method of Total Flavones from Viola Manshuricaw
20080
20 200217

About Zengchun Li

Zengchun Li is a scholar working on Cancer Research, Orthopedics and Sports Medicine and Molecular Biology, having authored 36 papers that have together received 578 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Metal-Organic Frameworks: Synthesis and Applications (3 papers), Bone fractures and treatments (3 papers), Hip and Femur Fractures (2 papers), Axon Guidance and Neuronal Signaling (2 papers), S100 Proteins and Annexins (2 papers) and Pain Mechanisms and Treatments (2 papers). The work is most often cited by research in Cancer Research (105 citations), Renewable Energy, Sustainability and the Environment (94 citations) and Rheumatology (83 citations). Zengchun Li has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Guofeng Li, Ning Han, Yuexiang Li, Shaoqin Peng, Gongxuan Lü, Jingren Xu, Yangzhou Liu, Lifeng Liu, Guoting Chen and Guang Li.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026